Modalis Therapeutics Corporation (TYO:4883)
Japan flag Japan · Delayed Price · Currency is JPY
29.00
+1.00 (3.57%)
Nov 18, 2026, 11:23 AM JST

Modalis Therapeutics Financials Overview

Millions JPY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
----401
Revenue Growth
----3900.00%-99.71%
Gross Profit
----401
Operating Income
-2,046-2,211-1,337-2,370-2,063-1,239
Net Income
-1,958-2,152-1,317-2,391-2,702-738
Earnings Per Share
-20.95-27.85-28.55-77.21-92.83-25.67
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
2,3682,8123,5751,8832,9334,936
Total Debt
---412--
Net Cash (Debt)
2,3682,8123,5751,4712,9334,936
Net Cash Growth
-22.24%-21.34%143.03%-49.85%-40.58%-8.95%
Net Cash Per Share
25.3436.3977.5047.50100.77171.67

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
--2,118-1,432-2,254-1,895-747
Capital Expenditures
--2--39-197-107
Free Cash Flow
--2,120-1,432-2,293-2,092-854
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
----100.00%100.00%
Operating Margin
-----5157.50%-123900.00%
Pretax Margin
-----6765.00%-74400.00%
Profit Margin
-----6755.00%-73800.00%
FCF Margin
-----5230.00%-85400.00%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-15.1215.1215.1243.6817.75
PS Ratio
----244.2417752.87